BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS Stock

Certificat

C5C3Z

DE000CU1CRW3

Market Closed - Euronext Paris 12:30:01 2024-04-26 EDT
2.957 EUR +6.02% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS
Current month-24.39%
1 month-19.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-04-26 2.957 +6.02% 100
24-04-25 2.789 -13.84% 102
24-04-24 3.237 -18.99% 94
24-04-23 3.996 +10.88% 97
24-04-22 3.604 +16.30% 102

Real-time Euronext Paris

Last update April 26, 2024 at 12:30 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
C5C3Z
ISINDE000CU1CRW3
Date issued 2019-04-15
Strike 191.4 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 8.1
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 21.62
Lowest since issue 2.746

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
221 CHF
Average target price
279.4 CHF
Spread / Average Target
+26.42%
Consensus
  1. Stock Market
  2. Certificates
  3. C5C3Z Certificat